PPBT
Purple Biotech
PPBT
PPBT
18 hedge funds and large institutions have $276K invested in Purple Biotech in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
+1
Holders Change %
+5.88%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
2
Closed
1
Calls
$5K
Puts
$2K
Net Calls
+$3K
Net Calls Change
-$68K
Top Buyers
| 1 |
KWA
Kingswood Wealth Advisors
San Diego,
California
|
$140K |
| 2 |
UBS Group
Zurich,
Switzerland
|
$2.22K |
| 3 |
JPMorgan Chase & Co
New York
|
$1.6K |
| 4 |
VVP
Venture Visionary Partners
Sylvania,
Ohio
|
$17.3K |
| 5 |
Morgan Stanley
New York
|
$36.2K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
$16K |
| 2 |
FA
Fiduciary Alliance
Greenville,
South Carolina
|
$0 |
| 3 |
Simplex Trading
Chicago,
Illinois
|
$8K |
